Jefferies Group’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
$974K Buy
+115,500
New +$974K 0.01% 493
2020
Q1
Sell
-11,756
Closed -$83K 1546
2019
Q4
$83K Buy
+11,756
New +$83K ﹤0.01% 1488
2019
Q2
Sell
-14,100
Closed -$177K 1767
2019
Q1
$177K Buy
+14,100
New +$177K ﹤0.01% 1245